Clinical Trials on Immune Response of 50 ug of ChulaCov19-BNA159 mRNA Vaccine
Total 15 results
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine... and other collaboratorsRecruitingSafety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response... and other conditionsThailand
-
Helsinki University Central HospitalUnknownMeasurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis AFinland, Sweden
-
Heinrich-Heine University, DuesseldorfRecruitingMultiple Sclerosis, Relapsing-Remitting | Vaccine Response ImpairedGermany
-
National Institute of Allergy and Infectious Diseases...CompletedPrevention of Zika Infection | Zika-Specific Immune ResponseUnited States
-
GlaxoSmithKlineCompletedRotavirus Infection | Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants
-
National Institute of Allergy and Infectious Diseases...CompletedPrevention of Zika Infection | Zika-Specific Immune ResponseUnited States
-
Neuroganics LLCRamos Injury Law FirmRecruitingCOVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | Vasculitis | Neuritis | Thrombocytopenia | Influenza | Corona Virus Infection | Blood Clot | Guillain-Barré | Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use | GWAS | Genetic SequencingUnited States
-
Children's Hospital of Chongqing Medical UniversityRecruitingHepatitis B Virus Infection | Hepatitis B Vaccine Adverse Reaction | Blood Transfusion Complication | Vaccination Reaction | Digestive System Disorders of Fetus and NewbornChina
-
University of British ColumbiaCenters for Disease Control and PreventionRecruiting
-
Tehran University of Medical SciencesRojanPharma Pharmaceutical CompanyCompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofIran, Islamic Republic of
-
National Taiwan University HospitalCompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofTaiwan
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)CompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofUnited States
-
University Hospital, LimogesRecruitingHepatitis C | Hepatitis C Virus Infection, Response to Therapy of | Addiction, Alcohol | Addiction Opiate | Transmission, Intravenous Drug AbuserFrance
-
National Taiwan University HospitalRecruitingHepatitis C Virus Infection | Hepatitis C Virus Infection, Response to Therapy of | Human Immunodeficiency Virus (HIV) CoinfectionTaiwan
-
Faculty Hospital Kralovske VinohradyCompletedInfections | Multiple Sclerosis | Autoimmune Diseases | Diabetes Mellitus, Type 1 | Rheumatoid Arthritis | Vaccine Reaction | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Down Syndrome | Atopic Dermatitis | Vitiligo | Alopecia Areata | COVID-19 Pandemic | Ankylosing Spondylitis | Lupus Erythematosus and other conditionsCzechia